drugset / Trial / NCT03031119
Multiple Ascending Dose and DDI Study
RandomizedParallel-groupDouble-blindBasic science
Summary
Part A will investigate the safety, tolerability, PK and PD of PF-06835919 administered for 14 days in a multiple ascending dose design. Part B will assess the effect of PF-06835919 co-administration at low and high doses on the PK of atorvastatin in a single cohort.
Timeline
- Start
- 2017-01
- Primary completion
- 2017-07
- Completion
- 2017-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | — | — |
| Subject | PF-06835919 | Small molecule | — | — |
Indications
No indication recorded.